Zobrazeno 1 - 10
of 19 892
pro vyhledávání: '"ST-SEGMENT ELEVATION"'
Autor:
Josep Gómez-Lara, Ramón López-Palop, Eva Rúmiz, Alfonso Jurado-Román, Antonio Gómez-Menchero, José Valencia, Estefanía Fernández, Luis Renier, Salvatore Brugaletta, Raúl Millán, Carlos Cortés, Paula Tejedor, Alejando Gutiérrez-Barrios, Xacobe Flores, Ana Belén Cid-Álvarez, Sergio García-Blas, Tamara García-Camarero, José Antonio Linares Vicente, Beatriz Vaquerizo, Juan Gabriel Córdoba Soriano, Juan Caballero, Rosa María Cardenal Piris, Guillermo Sánchez-Elvira, Loreto Oyarzabal, Alberto Pernigotti, Adrià Tramullas, Paula Antuña, Oriol Rodríguez-Leor, Soledad Ojeda, Xavier Rossello, Joan-Antoni Gómez-Hospital, Javier Bermejo, Héctor M. García-García, Armando Pérez de Prado, Enrique Gutiérrez-Ibañes
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 6, Iss 4, Pp 278-286 (2024)
ABSTRACT Introduction and objectives: The optimal treatment of nonculprit angiographic intermediate lesions (diameter stenosis 40%-69%) in patients with ST-segment elevation myocardial infarction (STEMI) is still unknown. Lesions with fractional flow
Externí odkaz:
https://doaj.org/article/b43f179e21c34bf99d401d9a022270fc
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract We retrospectively investigated the relationship between cardiopulmonary exercise testing (CPET) parameters and coronary microvascular dysfunction (CMD) using a novel angiography-based index of microcirculatory resistance (AccuIMR) in patien
Externí odkaz:
https://doaj.org/article/b9095ce77b094370bd3a022098d7323c
Autor:
Ravi Patel, Nathan DeRon Jr.
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by uninhibited platelet production. It can present with vasomotor symptoms, and less commonly, severe thrombotic events such as myocardial infarction. S
Externí odkaz:
https://doaj.org/article/2c4412b902fb4436a868b58af711580c
Publikováno v:
Medičnì Perspektivi, Vol 29, Iss 3, Pp 68-77 (2024)
Reperfusion therapy in myocardial infarction patients with acute ST-segment elevation significantly reduced the frequency of ventricular tachycardia and ventricular fibrillation, however, such arrhythmias still occur in 6-8% of patients, posing a thr
Externí odkaz:
https://doaj.org/article/4d8998e39e5645a4b832fbcd0fa1edad
Publikováno v:
Sālmand, Vol 19, Iss 3, Pp 470-483 (2024)
Objectives Little is known about the mortality rate of ST-segment elevation myocardial infarction (STEMI) in older people form low- and middle-income countries. Therefore, this study aims to investigate the predictors of one-year mortality in older p
Externí odkaz:
https://doaj.org/article/5842741dd3c04e58b278a937d17526b3
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 29, Iss 6, Pp n/a-n/a (2024)
ABSTRACT Background Patients with ST‐segment elevation myocardial infarction (STEMI) may have higher hospitalization costs and poorer prognosis than non‐ST‐segment elevation myocardial infarction (NSTEMI). Methods A single‐center retrospectiv
Externí odkaz:
https://doaj.org/article/23022a1bbd5a4393a0384aee20a7b5d1
Autor:
Jongkwang Kim, Byungeun Shon, Sangwook Kim, Jungrae Cho, Jung-Ju Seo, Se Yong Jang, Sungmoon Jeong
Publikováno v:
Frontiers in Physiology, Vol 15 (2024)
IntroductionAcute coronary syndrome (ACS) is one of the leading causes of death from cardiovascular diseases worldwide, with ST-segment elevation myocardial infarction (STEMI) representing a severe form of ACS that exhibits high prevalence and mortal
Externí odkaz:
https://doaj.org/article/d94cfe3d2aae432a84e65f720ba3ec29
Publikováno v:
Research Reports in Clinical Cardiology, Vol Volume 15, Pp 63-73 (2024)
Xianglian Bai,1 Aiwu Luo,2 Qin Liu,1 Xiaofeng Ma1 1The Affiliated Nanhua Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang City, Hunan Province, 421001, People’s Republic of China; 2Department of Healt
Externí odkaz:
https://doaj.org/article/6f2257564c2445169b906b1ef558c785
Publikováno v:
Xin yixue, Vol 55, Iss 8, Pp 624-630 (2024)
Objective To evaluate clinical efficacy of early application of sodium-glucose cotransporter-2 （SGLT-2） inhibitors combined with standard therapy for readmission ST-segment elevation myocardial infarction （STEMI） patients complicated with hea
Externí odkaz:
https://doaj.org/article/1ba843be6ac849f98cc1967f7ef7d614
Publikováno v:
The Egyptian Heart Journal, Vol 76, Iss 1, Pp 1-14 (2024)
Abstract Background Final infarct size (IS) after ST segment elevation myocardial infarction (STEMI) is a major predictor of mortality. Seeking early predictors for final IS can guide individualized therapeutic strategies for those recognized to be a
Externí odkaz:
https://doaj.org/article/9ec6fe41429644eda19c08149f52b7d3